2005P-0411
  

  
 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs 

  


  

  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC1654
  



  

  
Submitter : 
  

  
Dr. L. Mark Kimsey
  

  
Date & Time: 
  

  
02/13/2006 12:02:45
  



  

  
Organization : 
  

  
Dr. L. Mark Kimsey
  



  

  
Category : 
  

  
Health Professional
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 I am opposed to proposed restrictions on compounding pharmacies preparing bio-identical hormones. For the most part, the previous standards of care, namely Premarin and Provera, have proven to be poor medications. I believe they represent a danger to the public. On the contrary, bio- identical hormones have proven to be a blessing to my patients. Limitations on access to the medications would promote worsening health mainentance to many women.